WEDNESDAY, 13 JUNE
17:30: Reception at the Skandion Clinic, Scandinavia’s first clinic for proton therapy, including a guided tour.
THURSDAY, 14 JUNE
08:00 Registration opens
09:00 Official opening
09:15 Plenum session 1: A Visionary Outlook
Session objective: This session will draw the broad picture of why this summit is neeeded; the challenges ahead, including those from an equity of access and economic perspective. It also serves to shed light on the many opportunities, for example in bio-banks, data and registries that can create a positive trajectory forward.
- Dr. Susan Galbraith, Head of Oncology, iMed, Innovative Medicines, AstraZeneca
- Professor Klas Kärre, Chairman, the Swedish Cancer Society’s research committee
- Professor Max Parkin, Nuffield Dept. of Population Health, Oxford University
10:30 Coffeebreak, with delegate match-making
11:15 Workshops in parallel:
- Precision Medicine in Cancer Care
- Biobanking for Global Cancer Care
- Clinical Value and Price Setting for New Cancer Drugs
- Long Term Care for Cancer survivors
13:45 Workshops continue
15:15 Coffeebreak, with delegate match-making
16:00 Plenum Session 2: Patients as a driving force to develop care
- Gregory C. Simon J.D., President, Biden Cancer Initiative
- Ingela Franck Lissbrant, MD, PhD, Sahlgrenska University Hospital and Swedish National Prostate Cancer Registry
- Marie Ennis O'Connor, Patient Empowerment Foundation and Health Care Social Media.
- Kelechi Eguzo, MD, MPH, Nigerian Christian Hospital; Chairman Marjorie Bash Foundation, Nigeria
Session objective: In many parts of the world, patients and their kin claim an individual relation to healthcare, focusing on the patient. Expectations are high on receiving an individualized treatment; on transparency and on access to your own data. Many also want to contribute to the development of cancer care with their own data, generated inside or outside healthcare.
How will this development influence the relationship between healthcare and the individual patient? How can healthcare take advantage of the research advancements in precision medicine? How should patients be involved? And is a patient focus only a high income luxury or a possibility everywhere?
17:10 Reports from workshops
FRIDAY 15 JUNE
07:45 - 08:15 Optional morning walk in the Uppsala University Botanical Gardens. Meeting point by the gates at Dag Hammarsköldsväg - below the castle. See map in programme book.
08:45 Welcome back
09:00 Plenum session 3: Access to treatments and diagnostics
Session objective: Access to new cancer diagnostics and treatments is extremely unequally distributed, especially between high- and low income countries. Pharma industry has been strongly criticized for charging too much. But is it really that simple? Can we secure both access and an innovating industry?
- Dr. Mariângela Simão, WHO, Assistant Director General
- Professor Arnie Purushotham, King's College London and Tata Trust, Mumbai
- Thomas B. Cueni, Director General, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
10:00 Coffeebreak, with delegate match-making
10:45 Workshops in parallel:
- Towards Useful Biomarkers for Cancer Care
- Using Data for Better Cancer Treatments
- Implementing Physical Exercise in Cancer Care
- Cancer Drug Repositioning
13:15 Workshops continue
15:15 Plenum session 4: The threats against public health: Governance vs behavioural changes
Session objective: Lifestyle is responsible for 30 % of all cancer cases. Tobacco alone may explain 20 %. Is it responsible to lay the burden of changing lifestyle on the individual only? What can can international governance and politics achieve?
- Dr. Vinayak Mohan Prasad, Programme Manager, Tobacco Control, WHO
- Professor Mike Kelly, Institute of Public Health, University of Cambridge
- Professor Emerita Barbro Westerholm, Member of Swedish Parliament
- Professor Folke Tersman, Department of Philosophy, Uppsala University
16:25 Reports from workshops
16:55 Plenum Session 5 - Conclusions and take-home messages
A summarising dialogue with Programme Commmittee Chair Professor Emeritus Lars Holmberg and delegates.
17:15 Summit ends